BRIEF-Pfizer says 2 additional late stage studies of cholesterol drug met goals By: Reuters: Company News June 28, 2016 at 09:24 AM EDT * Two additional Phase 3 lipid-lowering studies of bococizumab deliver positive topline results Read More >> Related Stocks: Pfizer